|
|
 |
| Àâòîðèçàöèÿ |
|
|
|
| Ïîèñê ïî óêàçàòåëÿì |
|
|
|
|
|
|
|
 |
|
|
|
| Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells |
|
|
|
| Ïðåäìåòíûé óêàçàòåëü |
Mesoderm, intermediate 1: 276—277 1: 1:
Mesoderm, kidney formation and development in 1: 335
Mesoderm, lateral plate 1: 276—277
Mesoderm, notochord formation 1: 277
Mesoderm, origin 1: 273—275
Mesoderm, paraxial 1: 277
Mesoderm, splanchnic 1: 276
Mesoderm, structure and function 1: 273
Metaplasia, biologic significance 2: 139
Metaplasia, defined 2: 139
Microarray analysis 2: 29—30
Microarray analysis, amplification strategies in 2: 29—30
Microarray analysis, cDNA 2: 28 2: 2: 2:
Microarray analysis, confirmation studies 2: 647
Microarray analysis, data analysis 2: 29 2:
Microarray analysis, dataset comparisons 2: 30
Microarray analysis, differentiation studies 2: 648
Microarray analysis, experimental designs 2: 645
Microarray analysis, fibroblast gene expression patterns 2: 648 2:
Microarray analysis, future prospects 2: 648—649
Microarray analysis, Gene Ontology 2: 647
Microarray analysis, human ES cells 1: 408—410
Microarray analysis, oligonucleotide 2: 643—645 2:
Microarray analysis, postdata analysis 2: 647
Microarray analysis, progenitor cell line 1: 582 1: 1:
Microarray analysis, significance 2: 643
Microarray analysis, stem cell niche studies 2: 648
Microarray analysis, to identify sternness 2: 647—64b
Microarray target amplification 1: 408—409 1:
Microglia 2: 162
Microscopes 1: 437
Minor histocompatibility complex 1: 667
Mitogen-activated protein kinases (MAPKs) 1: 30 1: 1:
Mitogen-activated protein kinases (MAPKs) in epidermal stem cell differentiation 2: 250
Mitogen-activated protein kinases (MAPKs) in trophoblast development 1: 196—197
Mitogen-activated protein kinases (MAPKs), cell cycle role 2: 116—118
Monoallelic expression 1: 67 1: 1: 1:
Monoallelic expression in somatic cell nuclear transfer clones 1: 625—626
Morula 1: 143 1:
Motor neurons 1: 242
Motor neurons, regeneration from ES cells 1: 706 1: 1:
Motor neurons, therapeutic interventions 1: 246
Mouse, cell surface antigens 1: 565—566
Mouse, pluripotency of embryos 1: 639—652 (see also “Embryonic stem (ES) cells mouse”)
Mucin-secreting cells 2: 522
Mucopolysaccharidosis type VII 1: 691
Mucus neck cells 2: 522
Muller glial cells 1: 255 1:
Mullerian ducts 1: 345
Multilineage priming 2: 85—87 2:
Multiple myeloma 2: 621—622
Multiple sclerosis 1: 696 1:
Multipotency of neural crest cells 2: 225—226
Multipotency, bone marrow cell population 2: 722—724
Multipotency, defined 2: 13
Multipotency, epithelial skin stem cells 2: 257 2:
Multipotent adult progenitor cells 2: 84 2: 2: 2: 2:
Multipotent adult progenitor cells as hepatocyte progenitors 2: 489
Multipotent adult progenitor cells in adult neovascularization 2: 462
Multipotent adult progenitor cells in muscular dystrophy treatment 2: 723
Multipotent adult progenitor cells, characteristics 2: 723
Multipotent adult progenitor cells, differentiation 2: 293—294 2:
Multipotent adult progenitor cells, embryonic stem cells and 2: 90
Multipotent adult progenitor cells, global gene expression profile 2: 89—90
Multipotent adult progenitor cells, isolation and culturing 2: 293
Multipotent adult progenitor cells, neural cells derived from 1: 513
Multipotent adult progenitor cells, nonsenescent nature 2: 293
Multipotent adult progenitor cells, phenotype 2: 293
Multipotent adult progenitor cells, pluripotency 2: 294 2:
Multipotent adult progenitor cells, postnatal function 2: 294—295
Multipotent adult progenitor cells, transdifferentiation capacity 2: 477
Multipotent adult progenitor cells, tumorigenic potential 2: 294
Muscle cell differentiation 2: 107
Muscle regulatory factors 2: 395
Muscle stem cell, biologic significance 2: 395—396
Muscle stem cell, gene expression 2: 397—398
Muscle stem cell, injury 2: 399—400
Muscle stem cell, niche 2: 399
Muscle stem cell, plasticity 2: 395
Muscle stem cell, population heterogeneity 2: 397—398
Muscle stem cell, satellite cells and 2: 396—397 2:
Muscle stem cell, sources 2: 398—399 2:
Muscle, cardiac 2: 436—437
Muscle, processed lipoaspirate cells in formation of 2: 436—437
Muscle, slide population cells 2: 25
Muscle, tissue-engineered repair 2: 303 2:
Muscle-derived stem cells 2: 84
Muscle-derived stem cells, hematopoietic 2: 405—412
Muscular dystrophy 2: 396 2: 2:
Muscular dystrophy, clinical characteristics 2: 721
Muscular dystrophy, fiber regeneration during 2: 721
Muscular dystrophy, pathology 2: 725
Muscular dystrophy, treatment 2: 721—727
Muscular dystrophy, treatment, bone marrow transplantation 2: 722—724
Muscular dystrophy, treatment, future prospects 2: 726—727
Muscular dystrophy, treatment, myoblast transplantation 2: 721—722
Muscular dystrophy, treatment, stem cells with myogenic potential 2: 722—726 2:
Muscular dystrophy, treatment, strategies 2: 721
Mutagenesis, cell factors 1: 599
Mutagenesis, chemically-induced 1: 599—606
Mutagenesis, future research 1: 605—606
Mutagenesis, gene targeting techniques 1: 614
Mutagenesis, gene trapping techniques 1: 614—616
Mutagenesis, gene-based screening 1: 601—602 1:
Mutagenesis, library of mutagenized cells 1: 602—603 1:
Mutagenesis, site-specific recombination systems for 1: 609—620
Mutagenesis, types of mutations 1: 599—600
Mutagenesis, zebra fish model 1: 493 1:
Myc, in ES cell cycle regulation 1: 58
Myeloid genes in hematopoiesis 2: 87 2: 2: 2:
Myoblasts, multipotent adult progenitor cell-derived 2: 294
Myoblasts, satellite cell-derived 2: 397
Myoblasts, transplantation in muscular dystrophy 2: 721—722
Myocardial infarction 2: 600
Myocardial infarction, cardiac regeneration strategies 2: 714—717
Myocytes, amniotic fluid progenitor cell-derived 2: 178
Myocytes, myocardial regeneration 2: 711 2: 2:
MyoD 1: 112
Myofibers 2: 395 2:
Myofibroblasts, gastrointestinal 2: 522
Myogenic stem cells 2: 405
Myogenic stem cells, culturing 2: 574—577
Myogenic stem cells, definition 2: 571
Myogenic stem cells, fractionation 2: 578
Myogenic stem cells, isolation and characterization 2: 571—579
Myogenic stem cells, muscular dystrophy treatment 2: 721—722
Myosin heavy chain isoforms 2: 395
N-methyl-D-aspartate receptors 2: 221
Nanog 1: 38 1: 2:
Nanog in ES cell pluripotency 1: 132
Nanog in ES cell self-renewal 1: 49
National Institutes of Health 1: 793 1: 1: 2:
Natural killer cells in transplant rejection 1: 667—668
Natural killer cells, age-related changes 2: 749
Natural killer cells, development 2: 362—364
Natural killer cells, immune regulation 2: 748
Natural killer cells, origin 2: 347
Nematocytes 2: 53—54
Neomorphic allele mutations 1: 599
Nestin 1: 258 1: 1:
Nestin in islet precursor cells 1: 507 2:
Nestin, neural precursor cell expression 1: 516
Neural cell adhesion molecule 1: 512 1: 2: 2:
Neural crest cells 1: 219—229 2:
Neural crest cells in thymus and parathyroid development 1: 391 1:
Neural crest cells in thymus development 2: 556
Neural crest cells in tooth development 2: 280
Neural crest cells, axial patterning 1: 223f
Neural crest cells, biologic significance 2: 205
Neural crest cells, cell markers 1: 220
| Neural crest cells, clinical potential 1: 228—229
Neural crest cells, cranial vs. trunk 1: 226
Neural crest cells, cultivation 1: 243
Neural crest cells, culture conditions 2: 214
Neural crest cells, definition and characteristics 2: 205
Neural crest cells, derivative cell and tissue types, 1: 220f, 1: 226, 2: 206f 2: 208 2:
Neural crest cells, development 1: 219—220 2: 2: 2: 2:
Neural crest cells, development, growth factors in 2: 228
Neural crest cells, development, postmigratory potency and plasticity 2: 225—226
Neural crest cells, differentiation 2: 212—215 2: 2:
Neural crest cells, differentiation, restrictors 1: 226
Neural crest cells, function 2: 205
Neural crest cells, functional characteristics 1: 219 1:
Neural crest cells, intrinsic differences 2: 229—230
Neural crest cells, migration streams 2: 213—214
Neural crest cells, neural crest induction 1: 220—222
Neural crest cells, patterning 1: 222—225 1: 2:
Neural crest cells, peripheral nervous system development 2: 225—230
Neural crest cells, plasticity 1: 224—225
Neural crest cells, self renewal 2: 212 2:
Neural crest cells, sternness 1: 226—229 1: 2:
Neural crest cells, therapeutic potential 2: 215
Neural crest development 2: 225
Neural plate 1: 205—207 1: 1:
Neural precursor cells 1: 205—206 2: 2:
Neural precursor cells, cell markers 1: 515—516
Neural precursor cells, clinical significance 1: 511 1:
Neural precursor cells, clonal analysis 2: 587—588
Neural precursor cells, culturing 1: 239
Neural precursor cells, differentiation 1: 511—512 2:
Neural precursor cells, ES cell-derived 1: 504—506 1: 1: 1:
Neural precursor cells, sources 1: 513
Neural precursor cells, transplantation 1: 513 1: 2:
Neural retina 2: 703
Neural stem cells 1: 511 1: 2:
Neural stem cells from mesenchymal stem cells 2: 305
Neural stem cells in hematopoiesis 2: 84
Neural stem cells, antigenic markers 1: 688
Neural stem cells, cell cycle regulation 2: 74
Neural stem cells, characteristics 1: 687—688 1: 2:
Neural stem cells, clinical potential 1: 687 1: 1:
Neural stem cells, clinical potential in multimodal treatment 1: 693—697
Neural stem cells, clinical potential, brain repair 2: 697
Neural stem cells, clinical potential, cell replacement 1: 691—693
Neural stem cells, clinical potential, gene therapy 1: 691
Neural stem cells, clinical potential, neuron replacement/repair 1: 691—697 1:
Neural stem cells, current understanding 2: 581
Neural stem cells, defining characteristics 2: 581
Neural stem cells, differentiation 1: 238—239 1:
Neural stem cells, distribution 2: 13 2: 2: 2:
Neural stem cells, functional definition 1: 687 2:
Neural stem cells, gene expression profile 2: 89
Neural stem cells, glial characteristics 2: 219—220
Neural stem cells, growth factor response 2: 587
Neural stem cells, growth patterns in vitro 2: 586—587
Neural stem cells, isolation and culturing 1: 238—239 2:
Neural stem cells, migratory potential 1: 688—689 1: 1: 1:
Neural stem cells, neural crest cells and 1: 227—228
Neural stem cells, non-neural derivatives 1: 228
Neural stem cells, potency and plasticity 1: 228 1:
Neural stem cells, regenerative capacity 1: 687
Neural stem cells, research needs 1: 697—698
Neural stem cells, sources 1: 698
Neural stem cells, stem cell niches 2: 68
Neural stem cells, tissue collection 2: 582
Neuregulin 2: 227—228
Neuroepithelial bodies 2: 551—552
Neuroepithelial cells 1: 205 1: 1: 2:
Neuroepithelial cells in central nervous system development 2: 192—193
Neuroepithelial cells, central nervous system development 2: 197—200
Neurological disorders 1: 687
Neurological disorders, apoptosis-related 1: 693
Neurological disorders, dopaminergic system-related 1: 696
Neurological disorders, global disorders 1: 693 1:
Neurological disorders, hypoxia-ischemia-related 1: 696
Neurological disorders, potential applications of neural stem cell therapy 1: 688 1:
Neurons, amniotic fluid progenitor cell-derived 2: 178
Neurons, CNS development 1: 238
Neurons, dopaminergic 1: 241 —242
Neurons, ES cell differentiation 1: 107
Neurons, GAB A cells 1: 242—243
Neurons, glutamate type 1: 243
Neurons, glycinergic 1: 243
Neurons, hydra differentiation 2: 53
Neurons, lineage development 1: 573
Neurons, motor 1: 242
Neurons, multipotent adult progenitor cell-derived 2: 295
Neurons, nuclear transfer cloning from 1: 644
Neurons, olfactory system 2: 233
Neurons, pancreatic progenitors and 2: 518
Neurons, processed lipoaspirate cell-derived 2: 437—438
Neurons, radial glial precursors 2: 219—220
Neurons, regenerative capacity 1: 702—703 2: 2: 2:
Neurons, retinal, development 1: 254—256
Neurons, retinal, neurogenesis 2: 703—704
Neurons, retinal, regeneration 2: 704—706
Neurons, serotonergic 1: 242
Neurons, spinal cord 1: 701
Neurons, spine development 1: 704
Neurons, stem cell therapy challenges 2: 696
Neurospheres 1: 227 1: 1: 1: 2: 2:
Neurospheres, culturing 2: 586
Neurospheres, potency and plasticity 1: 228
Neurospheres, retinal 1: 255—257
Neurotrophin—3 2: 220
Newt heart 2: 451—452
Nodal 1: 136—138 1: 1: 1: 1:
Noelin-1 1: 221
Non-Hodgkin’s lymphoma 2: 688
Nonobese diabetic/severe combined immunodeficiency 1: 16 1: 1: 2: 2: 2: 2:
Normocin 1: 438
Notch signaling 1: 226 2: 2:
Notch signaling in cell cycle regulation 2: 77—78
Notch signaling in CNS development 2: 198—199
Notch signaling in epidermal stem cell differentiation 2: 251—253
Notch signaling in hematopoietic stem cell self-renewal 2: 313
Notch signaling in mammary cell regulation 2: 276
Notch signaling in neural crest cell fate decisions 2: 228—229
Notch signaling in neurogenesis 1: 212—213
Notch signaling in olfactory neurogenesis 2: 237
Notch signaling in pancreas development 2: 514
Notch signaling in thymus development 2: 167 2:
Notch signaling in tooth development 1: 266 1: 1:
Notochord 1: 277 1:
Notochord, Xenopus model 1: 486 1:
Nuclear factor of activated T-cells in chondrocyte differentiation 1: 289
Nuclear transfer cloning 1: 113—114 1: 1:
Nuclear transfer cloning by microinjection 1: 624
Nuclear transfer cloning, abnormal DNA methylation patterns in 1: 121—122
Nuclear transfer cloning, activated eggs in 1: 124
Nuclear transfer cloning, advantages 1: 629
Nuclear transfer cloning, cell sources 1: 642—645
Nuclear transfer cloning, clone birth weights 1: 628
Nuclear transfer cloning, culturing 1: 624
Nuclear transfer cloning, donor cell characteristics 1: 122—123
Nuclear transfer cloning, early attenuation of development in 1: 626—628
Nuclear transfer cloning, epigenetic processes in 2: 147
Nuclear transfer cloning, ethical issues in 1: 748
Nuclear transfer cloning, extraembryonic lineages 1: 628
Nuclear transfer cloning, future prospects 1: 124
Nuclear transfer cloning, implantation rate 1: 628
Nuclear transfer cloning, inefficiency 2: 147
Nuclear transfer cloning, limitations 1: 119 1:
Nuclear transfer cloning, nuclear transfer ES cells via 1: 628—629
Nuclear transfer cloning, oocyte enucleation in 1: 623—624
Nuclear transfer cloning, outcomes to date 1: 626—628 1:
Nuclear transfer cloning, pluripotency after 1: 640—647
Nuclear transfer cloning, recipient cytoplasm characteristics 1: 124 (see also “Somatic cell nuclear transfer”)
Nuclear transfer ES cells 1: 628—629
Nucleosomes, chromatin structure 2: 105
|
|
|
| Ðåêëàìà |
|
|
|
|
|
|
|
|
Î ïðîåêòå